Therefore, although long-term treatments might be associated with toxicity or reduced efficacy because of such regulatory loops, short-term OGA inhibition might still be effective for treatment of life-threatening acute hyperammonemia due to either inherited or acquired diseases. This evidence concerns the gene OGA and Hyperammonemia.